Clinical Trial Update: Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cardiovascular risk with drospirenone/ethinylestradiol and/or metformin in hyperinsulinemic women with polycystic ovary syndrome; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• drospirenone/ethinylestradiol (drospirenone and ethinylestradiol)
• metformin (metformin)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: COMPLETED